FROM Steve Scherer
Mixed messages from America's new hard line on Syria Last week, President Trump stunned the world by striking Syria with 59 Tomahawk missiles in retaliation for Bashar al-Assad's use of chemical weapons against his own people. Since then, American diplomats have made contradictory statements in the aftermath of the attack. Was it a "one-off" or is regime change the goal? And why has President Trump retaliated against Syria's use of chemical weapons — but not conventional weapons, which are just as deadly? America's G-7 allies are meeting in Italy to find a consensus for dealing with Syria -- and with Russia — the next stop for America's Secretary of State. Is it too soon for the "political solution" all sides claim to prefer, or will force be used in attempting to remove the Assad regime from power?
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
White House budget proposal slashes and burns President Trump's first budget request is considered dead on arrival in Congress — a familiar development in Capitol Hill. We hear what it reveals about the priorities of the new administration. What's likely to die… and what might survive?
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.